(Q40863199)

24 September 2017

title

The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis (English)

1 reference

24 September 2017

1

1 reference

24 September 2017

2

1 reference

24 September 2017

Fréderic Fumeron

4

0 references

Michel Marre

object named as

Michel Marre

5

0 references

Philippe Froguel

object named as

Philippe Froguel

9

0 references

author name string

Cédric Le May

3

1 reference

24 September 2017

Beverley Balkau

6

1 reference

24 September 2017

Guillaume Charpentier

7

1 reference

24 September 2017

Sylvia Franc

8

1 reference

24 September 2017

Bertrand Cariou

10

1 reference

24 September 2017

DESIR study group

11

1 reference

24 September 2017

publication date

7 June 2015

1 reference

24 September 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

published in

Diabetologia

1 reference

24 September 2017

volume

58

1 reference

24 September 2017

issue

9

1 reference

24 September 2017

page(s)

2051-2055

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-015-3659-8

24 September 2017

exact match

0 references

cites work

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

Effect of mutations in the PCSK9 gene on the cell surface LDL receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

PCSK9 is expressed in pancreatic delta-cells and does not alter insulin secretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

Genetic and metabolic determinants of plasma PCSK9 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-015-3659-8

10.1007/S00125-015-3659-8

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference